We are live on ! Find out more
VCYT icon

Veracyte

334 hedge funds and large institutions have $2.84B invested in Veracyte in 2026 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 143 increasing their positions, 101 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

694% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $854K

42% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 101

30% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 37

2% more funds holding

Funds holding: 329334 (+5)

1.48% more ownership

Funds ownership: 109.63%111.11% (+1.5%)

22% less capital invested

Capital invested by funds: $3.65B → $2.84B (-$805M)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
334
Holders Change
+5
Holders Change %
+1.52%
% of All Funds
4.08%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
48
Increased
143
Reduced
101
Closed
37
Calls
$6.78M
Puts
$854K
Net Calls
+$5.93M
Net Calls Change
+$717K

VCYT Hedge Fund Activity: Q1 2026 in Review

334 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2026, worth a combined $2.84B — down 22% from $3.65B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new VCYT positions and 37 closed out — a net gain of 11 holders — while 143 added to existing stakes and 101 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $75M. The largest seller was ARK Investment Management, cutting an estimated $30.9M.

  • 334 institutional investors held Veracyte (VCYT) as of Q1 2026, up from 329 in Q4 2025.
  • Funds reported $2.84B of Veracyte stock for Q1 2026, down 22% quarter-over-quarter.
  • 48 funds opened new Veracyte positions in Q1 2026 and 37 closed out, a net change of +11 holders.
  • The largest Veracyte buyer in Q1 2026 was Fidelity Investments, an estimated $75M added.
  • The largest Veracyte seller in Q1 2026 was ARK Investment Management, an estimated $30.9M sold.

Based on aggregated 13F filings for Q1 2026.